Life Sciences

Researchers have identified a significant drug-drug interaction between itraconazole, a common antifungal, and vepdegestrant, an experimental estrogen receptor degrader in development. The finding could affect dosing protocols and patient safety monitoring as the cancer drug advances through clinical trials and toward potential regulatory approval.EN

Researchers identified 14 patients with mutations in the RNU2-2 gene that triggers severe developmental epilepsy, intellectual disability, and seizures in infancy. The discovery could unlock new diagnostic pathways for hundreds of families with undiagnosed genetic epilepsies and guide development of targeted therapies for a previously unknown disease category.EN

Researchers respond to criticism of their nationwide finding that children born with orofacial clefts perform as well academically as peers without the condition. The response matters to healthcare systems and insurers evaluating treatment priorities and to families facing decisions about cleft repair timing and intensity.EN

A real-world study of nearly 400 ulcerative colitis patients shows infliximab works faster and better for severe cases, but adalimumab achieves identical remission rates over time. The finding could reshape treatment guidelines and reimbursement decisions, as adalimumab's lower cost and easier administration make it an increasingly attractive first-line option for milder disease.EN

Researchers have developed CoMR, a computational pipeline that identifies proteins in mitochondria far more accurately than existing methods, even in organisms with unusual biology. The advance could accelerate drug discovery and help decode how diseases arise in hard-to-study cells.EN

Researchers discovered that AI models trained on DNA-encoded chemical libraries fail when tested against novel compounds, limiting their use in drug discovery. The findings expose a critical flaw in current computational approaches and offer a roadmap for building more reliable prediction tools that could accelerate pharmaceutical development.EN

A new analysis questions whether neurofilament light chain—a blood marker used to track multiple sclerosis severity—is ready to replace traditional clinical measures in routine practice. The finding matters to drug developers and health systems betting on blood tests to simplify MS monitoring and cut healthcare costs.EN

A major reassessment of human genetic adaptation to agriculture finds that increased amylase gene copies—long cited as proof that farming shaped our biology—are actually driven by population history, not dietary change. The finding reshapes how researchers interpret genetic signatures of human evolution and raises questions about other widely accepted evolutionary narratives.EN

Researchers have identified structural changes in the hypothalamus—the brain's master clock—that explain why cluster headaches strike at predictable times of day and year. The finding suggests existing drugs that reset the body's circadian rhythm could be repurposed to prevent attacks, potentially redirecting a costly condition that disables sufferers for months at a time.EN

Researchers discovered that the hypothalamus—the brain's master control center—produces different hormones on each side, allowing the brain to target left and right body functions independently. This asymmetric system could reshape treatment strategies for neurological injuries, endocrine disorders, and conditions where one side of the body malfunctions.EN

Researchers have mapped the molecular mechanism that allows cancer cells to disable apoptosis—the programmed cell death that normally eliminates damaged cells. The findings, using advanced biophysical techniques, show exactly how the Bcl-2 protein sequesters Bax to prevent mitochondrial pores from opening, offering drugmakers a clearer target for cancer therapies.EN

A new paper calls for nursing education and practice to fundamentally embrace neurodiversity—treating autism and ADHD not as deficits but as different neurotypes requiring tailored care. As diagnoses rise and healthcare systems face pressure to improve outcomes, integrating neurodiversity principles into nursing theory could reshape patient satisfaction, clinical effectiveness, and institutional liability.EN

A new study of Scandinavian fish reveals a 75% female-bias in adult populations across a warming climatic gradient, despite stable genetic sex determination mechanisms. The finding suggests environmental factors—not genetics—are driving the skew, raising questions about how climate change may destabilize wild fish populations that support commercial fisheries and food security.EN

A new paper argues that the dominant framework for understanding heredity—rooted in early 20th-century Mendelian genetics—fails to explain how most traits actually develop. The finding matters for drug development, personalized medicine, and biotech strategy: companies betting on single-gene solutions may be missing the complex, interconnected biology driving disease and human variation.EN

Researchers found that removing SNAI2, a gene that drives aggressive breast cancer behavior, forces tumor cells to rely more heavily on aerobic metabolism while triggering cell death. The discovery suggests new drug targets for triple-negative breast cancer, a notoriously hard-to-treat form that lacks targeted therapies and accounts for significant patient mortality.EN

Researchers identified a genetic marker that could spare some early-stage breast cancer patients from intensive chemotherapy while directing it to those most likely to benefit. The finding, from the phase III PANTHER trial, could reduce unnecessary treatment toxicity and costs while improving survival outcomes for high-risk patients.EN

Researchers found that N-acetylglucosamine, an inexpensive oral supplement, reduced brain inflammation and preserved motor function in mice with fatal mitochondrial disease. The finding could accelerate development of treatments for a class of rare genetic disorders with no approved therapies, potentially opening a market for repurposed nutritional compounds.EN

Scientists have refined techniques for visualizing chromatin architecture—the physical arrangement of DNA in cell nuclei—with single-cell precision. The advances enable simultaneous tracking of DNA, RNA, and proteins, opening doors to better disease modeling and drug discovery while lowering technical barriers for labs without specialized expertise.EN

Researchers combined deep learning with explainability tools to identify autism from EEG brain signals while showing exactly which neural patterns triggered the diagnosis. The breakthrough addresses a critical gap: making AI-driven medical screening trustworthy enough for clinicians to adopt, potentially enabling earlier intervention in young children with autism.EN

Researchers have identified a signature of proteins in blood that can reliably detect inflammatory bowel disease in children, potentially replacing or supplementing the stool tests currently used. The finding could cut diagnostic delays—a persistent problem in pediatric IBD care—and improve treatment access for young patients who need faster answers.EN

Researchers have identified heme oxygenase-1 (HO-1) as both a prognostic marker and potential treatment target for leukemia and myelodysplastic syndrome. The finding could accelerate development of new therapeutics for blood cancers that affect hundreds of thousands annually, opening a fresh avenue for drug developers and diagnostics companies.EN

A new editorial highlights rising researchers tackling biofilms—bacterial communities that resist antibiotics and cause persistent infections costing healthcare systems billions annually. Understanding biofilm behavior could unlock treatments for drug-resistant infections and chronic diseases, reshaping antibiotic development and clinical practice.EN

Researchers have developed a polygenic risk score that uses common genetic variants to predict who will develop Alzheimer's disease, potentially decades in advance. The advance could reshape clinical trial recruitment, enable earlier interventions, and create a new market for preventive diagnostics—but raises questions about how employers and insurers might use genetic risk data.EN

Researchers have created the first comprehensive guide for using flow cytometry to analyze extracellular vesicles—tiny particles that cells release and that show promise as disease biomarkers. The standardization could accelerate development of diagnostic tests and therapeutics by giving labs a common measurement framework.EN

Genetisk risk för typ 2-diabetes kopplas till demensrisk, men det går att motverka genom hälsosam livsstil. Svenska forskare från Karolinska Institutet och GIH analyserade 437 732 personer från UK Biobank under i genomsnitt 13,3 år och fann 9 425 demensfall. En tydlig dos-responsrelation visades mellan polygent riskscore för diabetes och vaskulär demens, med kraftigt ökad risk över 95:e percentilen. Deltagare med låga livsstilspoäng (Life's Essential 8) hade genomgående högre demensrisk än de med moderate till höga poäng, oberoende av genetisk predisposition. Resultaten tyder på att beteendeförändringar—träning, kost, sömn, rökning—kan reducera demensrisken även hos genetiskt högriskindivider. För farmakologiska och preventiva interventioner betyder detta en marknad för lifestyle-baserad riskstratifiering och personaliserad demensförebyggande vård.